Insulin lispro Subcutaneous and Lomitapide Mesylate
Determining the interaction of Insulin lispro Subcutaneous and Lomitapide Mesylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin lispro
Brand name: Admelog, Humalog, HumaLOG Pen, HumaLOG KwikPen, HumaLOG Cartridge, HumaLOG Junior KwikPen, Admelog SoloStar, Humalog
Synonyms: Insulin lispro, Insulin Lispro
Generic Name: lomitapide
Brand name: Juxtapid
Synonyms: Lomitapide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin lispro Subcutaneous-Lomocot
- Insulin lispro Subcutaneous-Lomotil
- Insulin lispro Subcutaneous-Lomotil (Diphenoxylate and Atropine Solution)
- Insulin lispro Subcutaneous-Lomotil (Diphenoxylate and Atropine Tablets)
- Insulin lispro Subcutaneous-Lomustine
- Insulin lispro Subcutaneous-Long Lasting Nasal Spray
- Lomitapide Mesylate-Insulin NPH
- Lomitapide Mesylate-Insulin NPH (InnoLets, Pens, and PenFill Cartridges)
- Lomitapide Mesylate-Insulin NPH (Vials)
- Lomitapide Mesylate-Insulin NPH and Insulin Regular
- Lomitapide Mesylate-Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills)
- Lomitapide Mesylate-Insulin NPH and Insulin Regular (Vials)